Global Generic Injectable Drugs Market Growth (Status and Outlook) 2021-2026

  • receipt Report ID : 154556
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 131
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Generic Injectable Drugs will have significant change from previous year. By the most conservative estimates of global Generic Injectable Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 28200 million in 2019. Over the next five years the Generic Injectable Drugs market will register a 3.6% CAGR in terms of revenue, the global market size will reach US$ 32530 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Generic Injectable Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Small Molecule

Large Molecule

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Oncology

Anesthesia

Anti-Infectives

Parenteral Nutrition

Cardiovascular Diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Hospira (Pfizer Inc.)

Fresenius Kabi

Sandoz (Novartis)

Hikma Pharmaceuticals PLC

Dr. Reddy’s Laboratories Ltd

Grifols

Nichi-Iko Group (Sagent)

Teva Pharmaceutical

Auromedics

Sanofi

Gland Pharma

Endo International PLC

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Generic Injectable Drugs Market Size 2016-2026

2.1.2 Generic Injectable Drugs Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Generic Injectable Drugs Segment by Type

2.2.1 Small Molecule

2.2.2 Small Molecule

2.3 Generic Injectable Drugs Market Size by Type

2.3.1 Global Generic Injectable Drugs Market Size CAGR by Type

2.3.2 Global Generic Injectable Drugs Market Size Market Share by Type (2016-2021)

2.4 Generic Injectable Drugs Segment by Application

2.4.1 Oncology

2.4.2 Anesthesia

2.4.3 Anti-Infectives

2.4.4 Parenteral Nutrition

2.4.5 Cardiovascular Diseases

2.5 Generic Injectable Drugs Market Size by Application

2.5.1 Global Generic Injectable Drugs Market Size CAGR by Application

2.5.2 Global Generic Injectable Drugs Market Size Market Share by Application (2016-2021)

3 Global Generic Injectable Drugs by Players

3.1 Generic Injectable Drugs Market Size Market Share by Players

3.1.1 Global Generic Injectable Drugs Revenue by Players (2019-2021E)

3.1.2 Global Generic Injectable Drugs Revenue Market Share by Players (2019-2021E)

3.2 Global Generic Injectable Drugs Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Generic Injectable Drugs by Regions

4.1 Generic Injectable Drugs Market Size by Regions (2016-2021)

4.2 Americas Generic Injectable Drugs Market Size Growth (2016-2021)

4.3 APAC Generic Injectable Drugs Market Size Growth (2016-2021)

4.4 Europe Generic Injectable Drugs Market Size Growth (2016-2021)

4.5 Middle East & Africa Generic Injectable Drugs Market Size Growth (2016-2021)

5 Americas

5.1 Americas Generic Injectable Drugs Market Size by Country (2016-2021)

5.2 Americas Generic Injectable Drugs Market Size by Type (2016-2021)

5.3 Americas Generic Injectable Drugs Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Generic Injectable Drugs Market Size by Region (2016-2021)

6.2 APAC Generic Injectable Drugs Market Size by Type (2016-2021)

6.3 APAC Generic Injectable Drugs Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Generic Injectable Drugs by Country (2016-2021)

7.2 Europe Generic Injectable Drugs Market Size by Type (2016-2021)

7.3 Europe Generic Injectable Drugs Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Generic Injectable Drugs by Region (2016-2021)

8.2 Middle East & Africa Generic Injectable Drugs Market Size by Type (2016-2021)

8.3 Middle East & Africa Generic Injectable Drugs Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Generic Injectable Drugs Market Forecast

10.1 Global Generic Injectable Drugs Forecast by Regions (2021-2026)

10.1.1 Global Generic Injectable Drugs Forecast by Regions (2021-2026)

10.1.2 Americas Generic Injectable Drugs Forecast

10.1.3 APAC Generic Injectable Drugs Forecast

10.1.4 Europe Generic Injectable Drugs Forecast

10.1.5 Middle East & Africa Generic Injectable Drugs Forecast

10.2 Americas Generic Injectable Drugs Forecast by Countries (2021-2026)

10.2.1 United States Generic Injectable Drugs Market Forecast

10.2.2 Canada Generic Injectable Drugs Market Forecast

10.2.3 Mexico Generic Injectable Drugs Market Forecast

10.2.4 Brazil Generic Injectable Drugs Market Forecast

10.3 APAC Generic Injectable Drugs Forecast by Region (2021-2026)

10.3.1 China Generic Injectable Drugs Market Forecast

10.3.2 Japan Generic Injectable Drugs Market Forecast

10.3.3 Korea Generic Injectable Drugs Market Forecast

10.3.4 Southeast Asia Generic Injectable Drugs Market Forecast

10.3.5 India Generic Injectable Drugs Market Forecast

10.3.6 Australia Generic Injectable Drugs Market Forecast

10.4 Europe Generic Injectable Drugs Forecast by Country (2021-2026)

10.4.1 Germany Generic Injectable Drugs Market Forecast

10.4.2 France Generic Injectable Drugs Market Forecast

10.4.3 UK Generic Injectable Drugs Market Forecast

10.4.4 Italy Generic Injectable Drugs Market Forecast

10.4.5 Russia Generic Injectable Drugs Market Forecast

10.5 Middle East & Africa Generic Injectable Drugs Forecast by Region (2021-2026)

10.5.1 Egypt Generic Injectable Drugs Market Forecast

10.5.2 South Africa Generic Injectable Drugs Market Forecast

10.5.3 Israel Generic Injectable Drugs Market Forecast

10.5.4 Turkey Generic Injectable Drugs Market Forecast

10.5.5 GCC Countries Generic Injectable Drugs Market Forecast

10.6 Global Generic Injectable Drugs Forecast by Type (2021-2026)

10.8 Global Generic Injectable Drugs Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Hospira (Pfizer Inc.)

11.1.1 Hospira (Pfizer Inc.) Company Information

11.1.2 Hospira (Pfizer Inc.) Generic Injectable Drugs Product Offered

11.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Hospira (Pfizer Inc.) Main Business Overview

11.1.5 Hospira (Pfizer Inc.) Latest Developments

11.2 Fresenius Kabi

11.2.1 Fresenius Kabi Company Information

11.2.2 Fresenius Kabi Generic Injectable Drugs Product Offered

11.2.3 Fresenius Kabi Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Fresenius Kabi Main Business Overview

11.2.5 Fresenius Kabi Latest Developments

11.3 Sandoz (Novartis)

11.3.1 Sandoz (Novartis) Company Information

11.3.2 Sandoz (Novartis) Generic Injectable Drugs Product Offered

11.3.3 Sandoz (Novartis) Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Sandoz (Novartis) Main Business Overview

11.3.5 Sandoz (Novartis) Latest Developments

11.4 Hikma Pharmaceuticals PLC

11.4.1 Hikma Pharmaceuticals PLC Company Information

11.4.2 Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Offered

11.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Hikma Pharmaceuticals PLC Main Business Overview

11.4.5 Hikma Pharmaceuticals PLC Latest Developments

11.5 Dr. Reddy’s Laboratories Ltd

11.5.1 Dr. Reddy’s Laboratories Ltd Company Information

11.5.2 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product Offered

11.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Dr. Reddy’s Laboratories Ltd Main Business Overview

11.5.5 Dr. Reddy’s Laboratories Ltd Latest Developments

11.6 Grifols

11.6.1 Grifols Company Information

11.6.2 Grifols Generic Injectable Drugs Product Offered

11.6.3 Grifols Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Grifols Main Business Overview

11.6.5 Grifols Latest Developments

11.7 Nichi-Iko Group (Sagent)

11.7.1 Nichi-Iko Group (Sagent) Company Information

11.7.2 Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Offered

11.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Nichi-Iko Group (Sagent) Main Business Overview

11.7.5 Nichi-Iko Group (Sagent) Latest Developments

11.8 Teva Pharmaceutical

11.8.1 Teva Pharmaceutical Company Information

11.8.2 Teva Pharmaceutical Generic Injectable Drugs Product Offered

11.8.3 Teva Pharmaceutical Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Teva Pharmaceutical Main Business Overview

11.8.5 Teva Pharmaceutical Latest Developments

11.9 Auromedics

11.9.1 Auromedics Company Information

11.9.2 Auromedics Generic Injectable Drugs Product Offered

11.9.3 Auromedics Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Auromedics Main Business Overview

11.9.5 Auromedics Latest Developments

11.10 Sanofi

11.10.1 Sanofi Company Information

11.10.2 Sanofi Generic Injectable Drugs Product Offered

11.10.3 Sanofi Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Sanofi Main Business Overview

11.10.5 Sanofi Latest Developments

11. Gland Pharma

11.11.1 Gland Pharma Company Information

11.11.2 Gland Pharma Generic Injectable Drugs Product Offered

11.11.3 Gland Pharma Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Gland Pharma Main Business Overview

11.11.5 Gland Pharma Latest Developments

11.12 Endo International PLC

11.12.1 Endo International PLC Company Information

11.12.2 Endo International PLC Generic Injectable Drugs Product Offered

11.12.3 Endo International PLC Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Endo International PLC Main Business Overview

11.12.5 Endo International PLC Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Generic Injectable Drugs Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Small Molecule

Table 3. Major Players of Large Molecule

Table 4. Generic Injectable Drugs Market Size CAGR by Type (2016-2021) & ($ Millions)

Table 5. Global Generic Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 6. Global Generic Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 7. Generic Injectable Drugs Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 8. Global Generic Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 9. Global Generic Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 10. Global Generic Injectable Drugs Revenue by Players (2019-2021E) & ($ Millions)

Table 11. Global Generic Injectable Drugs Revenue Market Share by Players (2019-2021E)

Table 12. Global Generic Injectable Drugs Key Players Head office and Products Offered

Table 13. Generic Injectable Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Generic Injectable Drugs Market Size by Regions 2016-2021 & ($ Millions)

Table 17. Global Generic Injectable Drugs Market Size Market Share by Regions 2016-2021

Table 18. Americas Generic Injectable Drugs Market Size by Country (2016-2021) & ($ Millions)

Table 19. Americas Generic Injectable Drugs Market Size Market Share by Country (2016-2021)

Table 20. Americas Generic Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 21. Americas Generic Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 22. Americas Generic Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 23. Americas Generic Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 24. APAC Generic Injectable Drugs Market Size by Region (2016-2021) & ($ Millions)

Table 25. APAC Generic Injectable Drugs Market Size Market Share by Region (2016-2021)

Table 26. APAC Generic Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 27. APAC Generic Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 28. APAC Generic Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 29. APAC Generic Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 30. Europe Generic Injectable Drugs Market Size by Country (2016-2021) & ($ Millions)

Table 31. Europe Generic Injectable Drugs Market Size Market Share by Country (2016-2021)

Table 32. Europe Generic Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 33. Europe Generic Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 34. Europe Generic Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 35. Europe Generic Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 36. Middle East & Africa Generic Injectable Drugs Market Size by Region (2016-2021) & ($ Millions)

Table 37. Middle East & Africa Generic Injectable Drugs Market Size Market Share by Region (2016-2021)

Table 38. Middle East & Africa Generic Injectable Drugs Market Size by Type (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Generic Injectable Drugs Market Size Market Share by Type (2016-2021)

Table 40. Middle East & Africa Generic Injectable Drugs Market Size by Application (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Generic Injectable Drugs Market Size Market Share by Application (2016-2021)

Table 42. Key and Potential Regions of Generic Injectable Drugs

Table 43. Key Application and Potential Industries of Generic Injectable Drugs

Table 44. Key Challenges of Generic Injectable Drugs

Table 45. Key Trends of Generic Injectable Drugs

Table 46. Global Generic Injectable Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 47. Global Generic Injectable Drugs Market Size Market Share Forecast by Regions

Table 48. Global Generic Injectable Drugs Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 49. Global Generic Injectable Drugs Market Size Market Share Forecast by Type (2021-2026)

Table 50. Global Generic Injectable Drugs Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 51. Global Generic Injectable Drugs Market Size Market Share Forecast by Application (2021-2026)

Table 52. Hospira (Pfizer Inc.) Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 53. Hospira (Pfizer Inc.) Generic Injectable Drugs Product Offered

Table 54. Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 55. Hospira (Pfizer Inc.) Main Business

Table 56. Hospira (Pfizer Inc.) Latest Developments

Table 57. Fresenius Kabi Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 58. Fresenius Kabi Generic Injectable Drugs Product Offered

Table 59. Fresenius Kabi Main Business

Table 60. Fresenius Kabi Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 61. Fresenius Kabi Latest Developments

Table 62. Sandoz (Novartis) Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 63. Sandoz (Novartis) Generic Injectable Drugs Product Offered

Table 64. Sandoz (Novartis) Main Business

Table 65. Sandoz (Novartis) Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 66. Sandoz (Novartis) Latest Developments

Table 67. Hikma Pharmaceuticals PLC Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 68. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product Offered

Table 69. Hikma Pharmaceuticals PLC Main Business

Table 70. Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 71. Hikma Pharmaceuticals PLC Latest Developments

Table 72. Dr. Reddy’s Laboratories Ltd Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 73. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product Offered

Table 74. Dr. Reddy’s Laboratories Ltd Main Business

Table 75. Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 76. Dr. Reddy’s Laboratories Ltd Latest Developments

Table 77. Grifols Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 78. Grifols Generic Injectable Drugs Product Offered

Table 79. Grifols Main Business

Table 80. Grifols Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 81. Grifols Latest Developments

Table 82. Nichi-Iko Group (Sagent) Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 83. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product Offered

Table 84. Nichi-Iko Group (Sagent) Main Business

Table 85. Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 86. Nichi-Iko Group (Sagent) Latest Developments

Table 87. Teva Pharmaceutical Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 88. Teva Pharmaceutical Generic Injectable Drugs Product Offered

Table 89. Teva Pharmaceutical Main Business

Table 90. Teva Pharmaceutical Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 91. Teva Pharmaceutical Latest Developments

Table 92. Auromedics Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 93. Auromedics Generic Injectable Drugs Product Offered

Table 94. Auromedics Main Business

Table 95. Auromedics Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 96. Auromedics Latest Developments

Table 97. Sanofi Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 98. Sanofi Generic Injectable Drugs Product Offered

Table 99. Sanofi Main Business

Table 100. Sanofi Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 101. Sanofi Latest Developments

Table 102. Gland Pharma Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 103. Gland Pharma Generic Injectable Drugs Product Offered

Table 104. Gland Pharma Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 105. Gland Pharma Main Business

Table 106. Gland Pharma Latest Developments

Table 107. Endo International PLC Details, Company Type, Generic Injectable Drugs Area Served and Its Competitors

Table 108. Endo International PLC Generic Injectable Drugs Product Offered

Table 109. Endo International PLC Main Business

Table 110. Endo International PLC Generic Injectable Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 111. Endo International PLC Latest Developments

List of Figures

Figure 1. Generic Injectable Drugs Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Generic Injectable Drugs Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Generic Injectable Drugs Market Size Market Share by Type (2016-2021)

Figure 7. Generic Injectable Drugs in Oncology

Figure 8. Global Generic Injectable Drugs Market: Oncology (2016-2021) & ($ Millions)

Figure 9. Generic Injectable Drugs in Anesthesia

Figure 10. Global Generic Injectable Drugs Market: Anesthesia (2016-2021) & ($ Millions)

Figure 11. Generic Injectable Drugs in Anti-Infectives

Figure 12. Global Generic Injectable Drugs Market: Anti-Infectives (2016-2021) & ($ Millions)

Figure 13. Generic Injectable Drugs in Parenteral Nutrition

Figure 14. Global Generic Injectable Drugs Market: Parenteral Nutrition (2016-2021) & ($ Millions)

Figure 15. Generic Injectable Drugs in Cardiovascular Diseases

Figure 16. Global Generic Injectable Drugs Market: Cardiovascular Diseases (2016-2021) & ($ Millions)

Figure 17. Global Generic Injectable Drugs Market Size Market Share by Application in 2020

Figure 18. Global Generic Injectable Drugs Revenue Market Share by Player in 2020

Figure 19. Global Generic Injectable Drugs Market Size Market Share by Regions (2016-2021)

Figure 20. Americas Generic Injectable Drugs Market Size 2016-2021 ($ Millions)

Figure 21. APAC Generic Injectable Drugs Market Size 2016-2021 ($ Millions)

Figure 22. Europe Generic Injectable Drugs Market Size 2016-2021 ($ Millions)

Figure 23. Middle East & Africa Generic Injectable Drugs Market Size 2016-2021 ($ Millions)

Figure 24. Americas Generic Injectable Drugs Market Size Market Share by Country in 2020

Figure 25. Americas Generic Injectable Drugs Market Size Market Share by Type in 2020

Figure 26. Americas Generic Injectable Drugs Market Size Market Share by Application in 2020

Figure 27. United States Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 28. Canada Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 29. Mexico Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 30. APAC Generic Injectable Drugs Market Size Market Share by Regions in 2020

Figure 31. APAC Generic Injectable Drugs Market Size Market Share by Type in 2020

Figure 32. APAC Generic Injectable Drugs Market Size Market Share by Application in 2020

Figure 33. China Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 34. Japan Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 35. Korea Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 36. Southeast Asia Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 37. India Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 38. Australia Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 39. Europe Generic Injectable Drugs Market Size Market Share by Countries in 2020

Figure 40. Europe Generic Injectable Drugs Market Size Market Share by Type in 2020

Figure 41. Europe Generic Injectable Drugs Market Size Market Share by Application in 2020

Figure 42. Germany Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 43. France Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 44. UK Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 45. Italy Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 46. Russia Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 47. Middle East & Africa Generic Injectable Drugs Market Size Market Share by Region in 2020

Figure 48. Middle East & Africa Generic Injectable Drugs Market Size Market Share by Type in 2020

Figure 49. Middle East & Africa Generic Injectable Drugs Market Size Market Share by Application in 2020

Figure 50. Egypt Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 51. South Africa Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 52. Israel Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 53. Turkey Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 54. GCC Countries Generic Injectable Drugs Market Size Growth 2016-2021 ($ Millions)

Figure 55. Americas Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 56. APAC Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 57. Europe Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 58. Middle East & Africa Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 59. United States Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 60. Canada Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 61. Mexico Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 62. Brazil Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 63. China Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 64. Japan Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 65. Korea Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 66. Southeast Asia Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 67. India Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 68. Australia Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 69. Germany Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 70. France Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 71. UK Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 72. Italy Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 73. Russia Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 74. Spain Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 75. Egypt Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 76. South Africa Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 77. Israel Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 78. Turkey Generic Injectable Drugs Market Size 2021-2026 ($ Millions)

Figure 79. GCC Countries Generic Injectable Drugs Market Size 2021-2026 ($ Millions)